These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

995 related articles for article (PubMed ID: 14698276)

  • 21. Gastric Sleeve Surgery Alleviates Obesity-Associated Insulin Resistance and Suppresses Endoplasmic Reticulum Stress in Adipose Tissue of db/db Mice.
    Sun M; Zhao W; Li S; Li C; Feng Y; Geng D
    Obes Surg; 2019 Oct; 29(10):3220-3227. PubMed ID: 31197603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periodontal inflammation and insulin resistance--lessons from obesity.
    Nishimura F; Murayama Y
    J Dent Res; 2001 Aug; 80(8):1690-4. PubMed ID: 11669476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity.
    Kim OK; Jun W; Lee J
    Ann Nutr Metab; 2015; 67(4):218-27. PubMed ID: 26452040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
    Tam CS; Redman LM
    Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and chronic cardiovascular inflammatory syndrome.
    Fernández-Real JM; Ricart W
    Endocr Rev; 2003 Jun; 24(3):278-301. PubMed ID: 12788800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance, inflammation, and the prediabetic state.
    Haffner SM
    Am J Cardiol; 2003 Aug; 92(4A):18J-26J. PubMed ID: 12957323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fish oil reduces subclinical inflammation, insulin resistance, and atherogenic factors in overweight/obese type 2 diabetes mellitus patients: A pre-post pilot study.
    Souza DR; Pieri BLDS; Comim VH; Marques SO; Luciano TF; Rodrigues MS; De Souza CT
    J Diabetes Complications; 2020 May; 34(5):107553. PubMed ID: 32014347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation and Oxidative Stress in an Obese State and the Protective Effects of Gallic Acid.
    Dludla PV; Nkambule BB; Jack B; Mkandla Z; Mutize T; Silvestri S; Orlando P; Tiano L; Louw J; Mazibuko-Mbeje SE
    Nutrients; 2018 Dec; 11(1):. PubMed ID: 30577684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.
    Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
    Eur J Pharmacol; 2013 Sep; 715(1-3):246-55. PubMed ID: 23707905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes.
    Ndisang JF; Jadhav A
    Diabetes Obes Metab; 2013 Nov; 15(11):1029-39. PubMed ID: 23731386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between obesity, inflammation and insulin resistance: new concepts].
    Fève B; Bastard JP; Vidal H
    C R Biol; 2006 Aug; 329(8):587-97; discussion 653-5. PubMed ID: 16860277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus.
    Tataranni PA
    Eur Rev Med Pharmacol Sci; 2002; 6(2-3):27-32. PubMed ID: 12708607
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of resistin in obesity, insulin resistance and Type II diabetes.
    Kusminski CM; McTernan PG; Kumar S
    Clin Sci (Lond); 2005 Sep; 109(3):243-56. PubMed ID: 16104844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
    Esser N; Paquot N; Scheen AJ
    Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
    Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K
    Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity, inflammation, and insulin resistance.
    Shoelson SE; Herrero L; Naaz A
    Gastroenterology; 2007 May; 132(6):2169-80. PubMed ID: 17498510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of metaflammation as a systemic manifestation of metabolic diseases].
    Schäffler A
    Inn Med (Heidelb); 2023 Apr; 64(4):313-322. PubMed ID: 36346457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fructose-enriched diet induces inflammation and reduces antioxidative defense in visceral adipose tissue of young female rats.
    Kovačević S; Nestorov J; Matić G; Elaković I
    Eur J Nutr; 2017 Feb; 56(1):151-160. PubMed ID: 26433940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus.
    Hamada D; Maynard R; Schott E; Drinkwater CJ; Ketz JP; Kates SL; Jonason JH; Hilton MJ; Zuscik MJ; Mooney RA
    Arthritis Rheumatol; 2016 Jun; 68(6):1392-402. PubMed ID: 26713606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.